Heparin‐Modified Aligned Collagen Scaffolds Enhance In Vitro Myogenesis
Journal of Biomedical Materials Research Part A · 2026-02 · 114 (2)
DOI: 10.1002/jbma.70048 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biomedical Materials Research Part A, online erschienen am 10.02.2026. Verfasst von Geshani C Bandara und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical Engineering, University of Virginia, Charlottesville, Virginia, USA. Hauptthemen laut MEDLINE: Heparin, Tissue Scaffolds, Muscle Development, Collagen. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIAMS NIH HHS, NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Biomaterial‐based skeletal muscle tissue engineering approaches have largely focused on mimicking the 3D aligned architecture of native muscle, which is critical for guiding myotube formation and force transmission. In contrast, fewer studies incorporate glycosaminoglycan (GAG)‐mediated biochemical cues despite their known role in regulating myogenesis and growth factor sequestration. In this study, we develop aligned collagen‐GAG (CG) scaffolds using directional freeze‐drying and systematically vary GAG type by incorporating GAGs of increasing sulfation levels (hyaluronic acid, chondroitin sulfate, and heparin). While all scaffold variants support myoblast adhesion, metabolic activity, and myotube alignment, heparin‐modified CG scaffolds significantly enhance myoblast metabolic activity and myogenic differentiation as measured by myosin heavy chain (MHC) expression and myotube size. We additionally show that heparin‐modified scaffolds sequester and retain significantly higher levels of insulin‐like growth factor‐1 (IGF‐1), a potent promoter of myogenesis, compared to other scaffold groups. Together, these results highlight the importance of tailoring GAG type in CG scaffolds for targeted applications and underscore the promise of heparin‐modified CG scaffolds as a material platform for skeletal muscle tissue engineering.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemical Engineering, University of Virginia, Charlottesville, Virginia, USA.
- Department of Biomedical Engineering, University of Virginia, Charlottesville, Virginia, USA.
ORCID-Profile: Geshani C Bandara, Steven R Caliari
Förderung
- NIAMS NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
Bandara, G. C., Boudreau, R. D., Wyatt, W., & Caliari, S. R. (2026). Heparin‐Modified Aligned Collagen Scaffolds Enhance In Vitro Myogenesis. Journal of Biomedical Materials Research Part A, 114(2). https://doi.org/10.1002/jbma.70048
Vancouver
Bandara GC, Boudreau RD, Wyatt W, Caliari SR. Heparin‐Modified Aligned Collagen Scaffolds Enhance In Vitro Myogenesis. Journal of Biomedical Materials Research Part A. 2026;114(2). doi:10.1002/jbma.70048
BibTeX
@article{Bandara2026,
author = {Bandara, Geshani C and Boudreau, Ryann D and Wyatt, William and Caliari, Steven R},
title = {Heparin‐Modified Aligned Collagen Scaffolds Enhance In Vitro Myogenesis},
journal = {Journal of Biomedical Materials Research Part A},
year = {2026},
volume = {114},
number = {2},
doi = {10.1002/jbma.70048}
}
EUVIMED